UBS Group AG - REVIVA PHARMACEUTCLS HLDGS I ownership

REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPHW and the CUSIP is 76152G118. A total of 13 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of REVIVA PHARMACEUTCLS HLDGS I
ValueSharesWeighting
Q1 2023$1,670
+67.0%
1,670
-75.8%
0.00%
Q3 2022$1,0006,901
+1501.2%
0.00%
Q2 2022$0431
+84.2%
0.00%
Q3 2021$0234
+37.6%
0.00%
Q2 2021$0
-100.0%
170
-98.6%
0.00%
Q1 2021$6,000
+500.0%
12,457
+1070.8%
0.00%
Q4 2020$1,0001,0640.00%
Other shareholders
REVIVA PHARMACEUTCLS HLDGS I shareholders Q1 2021
NameSharesValueWeighting ↓
BOOTHBAY FUND MANAGEMENT, LLC 200,000$1,749,0000.06%
BlueCrest Capital Management Ltd 1,220,600$824,0000.02%
GLAZER CAPITAL, LLC 690,166$466,0000.02%
GABELLI & Co INVESTMENT ADVISERS, INC. 110,900$75,0000.01%
AQR Arbitrage LLC 250,000$169,0000.01%
Context Capital Management, LLC 39,300$27,0000.00%
RIVERNORTH CAPITAL MANAGEMENT, LLC 106,552$72,0000.00%
Walleye Capital LLC 64,959$44,0000.00%
Polar Asset Management Partners Inc. 300,907$197,0000.00%
HRT FINANCIAL LP 132,624$89,0000.00%
View complete list of REVIVA PHARMACEUTCLS HLDGS I shareholders